The longevity medicine community has begun integrating BPC-157 into broader protocols that address the biological underpinnings of aging: chronic low-grade inflammation, impaired tissue repair capacity, gut barrier dysfunction, and declining growth factor signaling
They are not a replacement for whole-food patterns, nor do they produce effects on par with GLP-1 receptor agonist medications
[DOI] [PubMed] [Google Scholar] 41.Misener V.L., Schachar R., Ickowicz A., Malone M., Roberts W., Tannock R., Kennedy J.L., Pathare T., Barr C.L
However, if tiredness or fatigue interferes with your daily life, talk with your doctor
GLP-1 agonists are medications originally developed for the treatment of diabetes that mimic our own GLP-1 hormone, says Juliana S
NauckMAMeierJJCavenderMAEl AzizMADruckerDJ